Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

TuHURA BIOSCIENCES, INC./NV (HURA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

TuHURA BIOSCIENCES, INC./NV (HURA), most recent 12 months reported: net loss $30.62M, free cash flow -$29.9M. Latest balance sheet on file: liquid cash $995.98K. From SEC filings. Others in Pharmaceutical Preparations: GRI BIO, INC. · GT Biopharma, Inc. · Hepion Pharmaceuticals, Inc. · WEREWOLF THERAPEUTICS, INC. · IMMIX BIOPHARMA, INC. · Immunome, Inc. · Imunon, Inc. · Immuneering Corporation

Stock screener

Watchlist